{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02989025",
            "orgStudyIdInfo": {
                "id": "2015-0029"
            },
            "organization": {
                "fullName": "University of Mississippi Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia",
            "officialTitle": "Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study",
            "acronym": "PROGRESS",
            "therapeuticArea": [
                "Women's Health"
            ],
            "study": "progesterone-to-enhance-the-efficacy-and-success-of-expectantly-managed-preterm-severe-superimposed-preeclampsia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-05-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-11-28",
            "studyFirstSubmitQcDate": "2016-12-09",
            "studyFirstPostDateStruct": {
                "date": "2016-12-12",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-05-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Babbette Lamarca",
                "investigatorTitle": "Chair and Professor, Pharmacology and Toxicology",
                "investigatorAffiliation": "University of Mississippi Medical Center"
            },
            "leadSponsor": {
                "name": "Babbette Lamarca",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to learn if giving 17-hydroxyprogesterone caproate (17 OHPC) to mothers with preeclampsia diagnosed before 34 weeks gestation improves mother and baby outcomes.",
            "detailedDescription": "The OBGYN house and attending staff on duty caring for the patient will determine appropriateness for study inclusion. The treating physician will then immediately contact the MFM fellow on call and Research Division personnel to facilitate the initiation of study procedures, including the consent process and baseline blood tests. Once enrolled with informed consent, the participant will receive 17 OHPC, 250mg IM to be given at admission and every 7 days thereafter. Blood sampling of approximately 1-2 teaspoons each will be collected at baseline immediately prior to administration of 17 OHPC, then 24 hours (+-2hrs). After the first 24 hours, blood samples will be collected every 72 hrs until delivery and again 24hrs (+- 2hrs) after delivery. Placentas will be collected at delivery and the investigators will also collect information of the mother and newborn while in the hospital and until discharge including de-identified routine ultrasound."
        },
        "conditionsModule": {
            "conditions": [
                "Pregnancy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Experimental",
                    "type": "EXPERIMENTAL",
                    "description": "To determine if the addition of 17 OHPC to the management of Severe PE diagnosed prior to 34 weeks gestation improves maternal and perinatal outcomes.",
                    "interventionNames": [
                        "Drug: 17 OHPC"
                    ]
                },
                {
                    "label": "Control",
                    "type": "NO_INTERVENTION",
                    "description": "To determine how close the molecular markers are with 17 OHPC added to the management protocol."
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "17 OHPC",
                    "description": "The study participant will be given 17 OHPC, 250mg IM at admission and every 7 days thereafter.",
                    "armGroupLabels": [
                        "Experimental"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Improvement of maternal and perinatal outcomes",
                    "description": "Assessment of maternal BP trends",
                    "timeFrame": "Baseline"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change is being assessed in Maternal Outcomes",
                    "description": "Assessment of maternal BP trends",
                    "timeFrame": "24 hours"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change is being assessed in Maternal Outcomes",
                    "description": "Assessment of maternal BP trends",
                    "timeFrame": "48 hours"
                },
                {
                    "measure": "Change is being assessed in Maternal Outcomes",
                    "description": "Assessment of maternal BP trends",
                    "timeFrame": "Until delivery"
                },
                {
                    "measure": "Assessment of Placental Abruption",
                    "description": "Assessment of Placental Abruption",
                    "timeFrame": "Baseline until delivery"
                },
                {
                    "measure": "Assessment of Pulmonary edema",
                    "description": "Assessment of Pulmonary edema",
                    "timeFrame": "Change from Baseline until delivery"
                },
                {
                    "measure": "Assessment of Acute Kidney Injury",
                    "description": "Assessment of Acute Kidney Injury",
                    "timeFrame": "Change from Baseline until delivery"
                },
                {
                    "measure": "Assessment of DIC",
                    "description": "Assessment of DIC",
                    "timeFrame": "Change from Baseline until delivery"
                },
                {
                    "measure": "Assessment of neurological events",
                    "description": "Assessment of neurological events",
                    "timeFrame": "Change from Baseline until delivery"
                },
                {
                    "measure": "Assessment of laboratory results",
                    "description": "Assessment of laboratory results",
                    "timeFrame": "Change from Baseline until delivery"
                },
                {
                    "measure": "Assessment of Biomarkers",
                    "description": "Assessment of Biomarkers",
                    "timeFrame": "Change from Baseline until delivery"
                },
                {
                    "measure": "Assessment of Infant Weight",
                    "description": "Assessment of Infant Weight",
                    "timeFrame": "Delivery"
                },
                {
                    "measure": "Assessment of APGAR score",
                    "description": "Assessment of APGAR score",
                    "timeFrame": "Delivery"
                },
                {
                    "measure": "Assessment of NICU stays",
                    "description": "Assessment of NICU stays",
                    "timeFrame": "Delivery"
                },
                {
                    "measure": "Assessment of Interventricular hemorrhage",
                    "description": "Assessment of Interventricular hemorrhage",
                    "timeFrame": "Delivery"
                },
                {
                    "measure": "Assessment of Respiratory Distress Syndrome",
                    "description": "Assessment of Respiratory Distress Syndrome",
                    "timeFrame": "Delivery"
                },
                {
                    "measure": "Assessment of Necrotizing enterocolitis (NEC)",
                    "description": "Assessment of Necrotizing enterocolitis (NEC)",
                    "timeFrame": "Delivery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* UMMC antepartum patients with preterm PE between 23 0/7ths and 34 0/7ths weeks gestation when initially evaluated\n* Willing and able to understand study procedures and to provide informed consent\n\nExclusion Criteria:\n\n* \\>33 weeks gestational age or \\<23 weeks gestation\n* Maternal compromise requiring emergent delivery (ongoing placental abruption, DIC, pulmonary edema).\n* Fetal compromise requiring emergent delivery (fetal bradycardia, recurrent late fetal heart rate decelerations, minimal to absent fetal heart rate variability).\n* Parameters according to current practice guidelines that exclude a patient from expectant management include the following:\n* Preterm premature rupture of membranes (PPROM) \\> 34 weeks gestation;\n* Platelet count \\< 100,000/microliter (thrombocytopenia) with evidence of HELLP syndrome;\n* Persistently abnormal hepatic enzyme concentrations (twice or more upper normal values);\n* Severe fetal growth restriction (ultrasound-estimated fetal weight less than fifth percentile);\n* Severe Oligohydramnios (AFI \\< 5cm)\n* Reversal of end diastolic flow(REDF) in umbilical artery Doppler testing;\n* Recurrent (\\> 2 readings \\> 30 minutes apart) severe hypertension despite antihypertensive therapy;\n* Eclampsia;\n* Pulmonary edema;\n* Abruption placentae;\n* Nonreassuring fetal status during daily testing (biophysical profile \\<4/10 and/or recurrent variable or late decelerations);\n* IUFD",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "45 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Babbette LaMarca, PhD",
                    "role": "CONTACT",
                    "phone": "(601)815-1430",
                    "email": "bblamarca@umc.edu"
                },
                {
                    "name": "Lorena M Amaral, Ph.D.",
                    "role": "CONTACT",
                    "email": "lmamaral@umc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Babbette LaMarca, PhD",
                    "affiliation": "University of Missisippi Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Sheila S Belk",
                    "affiliation": "UMMC Pharmacology and Toxicology",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Winfred L. Wiser Hospital",
                    "status": "RECRUITING",
                    "city": "Jackson",
                    "state": "Mississippi",
                    "zip": "39216",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Babbette LaMarca, PhD",
                            "role": "CONTACT",
                            "phone": "601-815-1430",
                            "email": "bblamarca@umc.edu"
                        },
                        {
                            "name": "Sheila Belk, MSCI",
                            "role": "CONTACT",
                            "phone": "(601)984-1690",
                            "email": "sbelk@umc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.29876,
                        "lon": -90.18481
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011225",
                    "term": "Pre-Eclampsia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000046110",
                    "term": "Hypertension, Pregnancy-Induced"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M25869",
                    "name": "Premature Birth",
                    "relevance": "LOW"
                },
                {
                    "id": "M14106",
                    "name": "Pre-Eclampsia",
                    "asFound": "Preeclampsia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7633",
                    "name": "Eclampsia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M25635",
                    "name": "Hypertension, Pregnancy-Induced",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "T2019",
                    "name": "Eclampsia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M14245",
                    "name": "Progesterone",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}